Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Alonso

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Puerto Rico Health Sciences Journal|June 11, 2024
Psychometric Properties of the Family Adaptability and Cohesion Evaluation Scale III in Latin American University Dental StudentsVíctor Díaz-Narváez, Alejandro Reyes-Reyes, Ana María Erazo-Coronado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2024
Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndromeTeresa Bada-Bosch, Angel M Sevillano, María Teresa Sánchez-Calvin, et al.
Methods and Protocols|October 26, 2022
Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional StudyJorge Nuche, Javier de la Cruz Bertolo, Irene Marco Clement, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|July 23, 2025
Resilience as a Predictor of Empathy in Dental Students in Latin America: A Multicentre StudyVíctor P Díaz-Narváez, José Gamarra-Moncayo, Natalia Fortich-Mesa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Puerto Rico Health Sciences Journal|June 11, 2024
Psychometric Properties of the Family Adaptability and Cohesion Evaluation Scale III in Latin American University Dental StudentsVíctor Díaz-Narváez, Alejandro Reyes-Reyes, Ana María Erazo-Coronado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2024
Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndromeTeresa Bada-Bosch, Angel M Sevillano, María Teresa Sánchez-Calvin, et al.
Methods and Protocols|October 26, 2022
Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional StudyJorge Nuche, Javier de la Cruz Bertolo, Irene Marco Clement, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|July 23, 2025
Resilience as a Predictor of Empathy in Dental Students in Latin America: A Multicentre StudyVíctor P Díaz-Narváez, José Gamarra-Moncayo, Natalia Fortich-Mesa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Pageof 9